Wikidata

(Q54352127)

English

A phase 1/2 of a combination of cetuximab and taxane for "triple negative" breast cancer patients.

scientific article

In more languages

Statements

title
A phase 1/2 of a combination of cetuximab and taxane for "triple negative" breast cancer patients. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24836394
retrieved
28 May 2018
reference URL
http://europepmc.org/abstract/MED/24836394

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q54352127&oldid=1189878344"